Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.
Wahl M, Phillips JJ, Molinaro AM, Lin Y, Perry A, Haas-Kogan DA, Costello JF, Dayal M, Butowski N, Clarke JL, Prados M, Nelson S, Berger MS, Chang SM.
Wahl M, et al. Among authors: lin y.
Neuro Oncol. 2017 Feb 1;19(2):242-251. doi: 10.1093/neuonc/now176.
Neuro Oncol. 2017.
PMID: 27571885
Free PMC article.
Clinical Trial.